Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Cited by (587)

Items 301–400 of 587

1. A broadly generalizable stabilization strategy for sarbecovirus fusion machinery vaccines
   Lee, Jimin, Stewart, Cameron, Schäfer, Alexandra, Leaf, Elizabeth M., Park, Young-Jun, Asarnow, Daniel, Powers, John M., Treichel, Catherine, Sprouse, Kaitlin R., Corti, Davide et al. · 2024 · Nature Communications
2. Single-molecule imaging reveals allosteric stimulation of SARS-CoV-2 spike receptor binding domain by host sialic acid
   Marco Aurelio Díaz-Salinas, Aastha Jain, Natasha D. Durham, James B. Munro · 2024 · Science Advances
3. Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans
   Amin Addetia, Cameron Stewart, Albert J. Seo, Kaitlin R. Sprouse, Ayed Y. Asiri, Maha Al-Mozaini, Ziad Ahmed Memish, Abeer N. Alshukairi, David Veesler · 2024 · Cell Reports
4. Crystal structures of the SARS‐CoV‐2 nucleocapsid protein C‐terminal domain and development of nucleocapsid‐targeting nanobodies
   Zhenghu Jia, Chen Liu, Yuewen Chen, Heng Jiang, Zijing Wang, Jialu Yao, Jie Yang, Jiaxing Zhu, Boqing Zhang, Zhiguang Yuchi · 2021 · FEBS Journal
5. Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
   Thomas Desautels, Adam T Zemla, Edmond Y. Lau, Magdalena Franco, Daniel Faissol · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
6. Mass Spectrometry-based Proteomics and Glycoproteomics in COVID-19 Biomarkers Identification: A Mini-review
   L L D Zhong, Lin Zhu, Zongwei Cai · 2021 · Journal of Analysis and Testing
7. Computational design of a neutralizing antibody with picomolar binding affinity for all concerning SARS-CoV-2 variants
   Bo-Seong Jeong, Jeong Seok Cha, Insu Hwang, Uijin Kim, Jared Adolf‐Bryfogle, Brian Coventry, Hyun‐Soo Cho, Kyun‐Do Kim, Byung‐Ha Oh · 2022 · mAbs
8. Design of customized coronavirus receptors
   Peng Liu, Meiling Huang, Hua Guo, Matthew McCallum, Jun-Yu Si, Yuanmei Chen, Chunli Wang, Yu Xiao, Lulu Shi, Qing Xiong et al. · 2024 · Nature
9. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of “Up” versus “Down” protomer states
   Michael H. Peters, Oscar H. Bastidas, Daniel S. Kokron, Christopher E. Henze · 2020 · PLoS ONE
10. Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective
    Yashwant Kumar Ratre, Namrata Kahar, Lakkakula VKS Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma · 2021 · 3 Biotech
11. Coronavirus (2019-nCoV) Deactivation via Spike Glycoprotein Shielding by Old Drugs, Bioinformatic Study
    Mohammad Reza Dayer · 2020 · Preprints.org
12. Snapshot of the evolution and mutation patterns of SARS-CoV-2
    Jin Zhao, Jiumeng Sun, Wanting He, Xiang Ji, Qi Gao, Xiaofeng Zhai, Marc A. Suchard, Samuel Leandro Hong, Guy Baele, Shuo Su et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
13. Structural basis for broad sarbecovirus neutralization by a human monoclonal antibody
    M. Alejandra Tortorici, Nadine Czudnochowski, Tyler N. Starr, Roberta Marzi, Alexandra C. Walls, Fabrizia Zatta, John E. Bowen, Stefano Jaconi, Julia di Iulio, Zhaoqian Wang et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
14. SARS-CoV-2 spike conformation determines plasma neutralizing activity
    John E. Bowen, Alexandra C. Walls, Anshu Joshi, Kaitlin R. Sprouse, Cameron Stewart, M. Alejandra Tortorici, Nicholas Franko, Jennifer K. Logue, Ignacio G. Mazzitelli, Sasha W. Tilles et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
15. Recognition of Potential COVID-19 Drug Treatments through the Study of Existing Protein–Drug and Protein–Protein Structures: An Analysis of Kinetically Active Residues
    Ognjen Perišić · 2020 · Biomolecules
16. Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
    Anish Nag, Ritesh Banerjee, Rajshree Roy Chowdhury, Chandana Krishnapura Venkatesh · 2021 · VirusDisease
17. hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics
    Chengbo Chen, Richard Zhu, Edgar A. Hodge, Marco Aurelio Díaz-Salinas, Adam Nguyen, James B. Munro, Kelly K. Lee · 2023 · ACS Infectious Diseases
18. N-glycosylation of infectious bronchitis virus M41 spike determines receptor specificity
    Kim M. Bouwman, N. Habraeken, Andrea Laconi, Alinda J. Berends, L. Groenewoud, M. Alders, Vera Kemp, Monique H. Verheije · 2020 · Journal of General Virology
19. Flexibility and mobility of SARS-CoV-2-related protein structures
    Rudolf A. Römer, Navodya S. Römer, A. Katrine Wallis · 2021 · Scientific Reports
20. Bovine Coronavirus Immune Milk Against COVID-19
    Antonio José Arenas, Carmen Borge, Alfonso Carbonero, Ignacio García‐Bocanegra, David Cano‐Terriza, Javier Caballero‐Gómez, Antonio Arenas‐Montes · 2021 · Frontiers in Immunology
21. Pathogenesis, Diagnosis and Possible Therapeutic Options for COVID-19
    Md. Asad Ullah, Yusha Araf, Bishajit Sarkar, Abu Tayab Moin, Riyan Al Islam Reshad, MD. Hasanur Rahman · 2020 · Journal of Clinical and Experimental Investigations
22. Production of scFv, Fab, and IgG of CR3022 Antibodies Against SARS-CoV-2 Using Silkworm-Baculovirus Expression System
    Takeru Ebihara, Akitsu Masuda, Daisuke Takahashi, Masato Hino, Hiroaki Mon, Kohei Kakino, Tsuguru Fujii, Ryosuke Fujita, Tadashi Ueda, Jae Man Lee et al. · 2021 · Molecular Biotechnology
23. Isolation of cross-reactive monoclonal antibodies against divergent human coronaviruses that delineate a conserved and vulnerable site on the spike protein
    Wang, Chunyan, van Haperen, Rien, Gutiérrez-Álvarez, Javier, Li, Wentao, Okba, Nisreen M.A., Albulescu, Irina, Widjaja, Ivy, van Dieren, Brenda, Fernandez-Delgado, Raul, Sola, Isabel et al. · 2020
24. Designed miniproteins potently inhibit and protect against MERS-CoV
    Robert J. Ragotte, M. Alejandra Tortorici, Nicholas Catanzaro, Amin Addetia, Brian Coventry, Heather M. Froggatt, Jimin Lee, Cameron Stewart, Jack T Brown, Inna Goreshnik et al. · 2025 · Cell Reports
25. Prefusion structure, evasion and neutralization of HSV-1 glycoprotein B
    Ryan S. Roark, Andrew J. Schaub, Wei Shi, Maple Wang, Fabiana A. Bahna, Jordan E. Becker, Andrea Biju, Sue Chong, Haijuan Du, Yicheng Guo et al. · 2025 · Nature Microbiology
26. De novo design and Rosetta‐based assessment of high‐affinity antibody variable regions (Fv) against the SARS‐CoV ‐2 spike receptor binding domain ( RBD )
    Veda Sheersh Boorla, Ratul Chowdhury, Ranjani Ramasubramanian, Brandon Ameglio, Rahel Frick, Jeffrey J. Gray, Costas D. Maranas · 2022 · Proteins Structure Function and Bioinformatics
27. Integration of Power-Free and Self-Contained Microfluidic Chip with Fiber Optic Particle Plasmon Resonance Aptasensor for Rapid Detection of SARS-CoV-2 Nucleocapsid Protein
    Ting-Chou Chang, Aileen Y. Sun, Yu‐Chung Huang, Chih-Hui Wang, Shau‐Chun Wang, Lai‐Kwan Chau · 2022 · Biosensors
28. Spike-protein proteolytic antibodies in COVID-19 convalescent plasma contribute to SARS-CoV-2 neutralization
    Scott A. McConnell, Jaiprasath Sachithanandham, Nathan J. Mudrak, Xianming Zhu, Parsa Alba Farhang, Radamés J. B. Cordero, Maggie P. Wear, Janna R. Shapiro, Han-Sol Park, Sabra L. Klein et al. · 2023 · Cell chemical biology
29. Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain
    Rajeshwer Singh Sankhala, Vincent Dussupt, Wei‐Hung Chen, Hongjun Bai, Elizabeth J. Martinez, Jaime L. Jensen, Phyllis A. Rees, Agnes Hajduczki, William C. Chang, Misook Choe et al. · 2023 · Structure
30. Cerium Oxide Nanoparticles for Biomedical Applications
    Arumugam Vijayan, Shalini Ramadoss, Natarajan Sisubalan, Muniraj Gnanaraj, Chandrasekaran Karthikeyan, Varaprasad Kokkarachedu · 2024 · Nanotechnology in the life sciences
31. Oligomerization-driven avidity correlates with SARS-CoV-2 cellular binding and inhibition
    Roi Asor, Anna Olerinyova, Sean Anthony Burnap, Manish Singh Kushwah, Fabian Soltermann, Lucas S. P. Rudden, Mario Hensen, Snežana Vasiljević, Juliane Brun, Michelle L. Hill et al. · 2024 · Proceedings of the National Academy of Sciences
32. Antibody therapies for the treatment of COVID-19
    Zhiqiang Ku, Xiaohua Ye, Georgina To’a Salazar, Ningyan Zhang, Zhiqiang An · 2020 · Antibody Therapeutics
33. Current diagnostic and therapeutic strategies for COVID-19
    Binbin Chen, Mengli Liu, Chengzhi Huang · 2021 · Journal of Pharmaceutical Analysis
34. Structural Dynamics and Molecular Evolution of the SARS-CoV-2 Spike Protein
    Kyle Wolf, Jason C. Kwan, Jeremy P. Kamil · 2022 · mBio
35. DGraph Clusters Flaviviruses and β-Coronaviruses According to Their Hosts, Disease Type, and Human Cell Receptors
    Benjamin A. Braun, Catherine H. Schein, Werner A. Braun · 2021 · Bioinformatics and Biology Insights
36. Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study
    Luana Janaína de Campos, Nicholas Y. Palermo, Martin Conda‐Sheridan · 2021 · The Journal of Physical Chemistry B
37. An entropic safety catch controls hepatitis C virus entry and antibody resistance
    Lenka Stejskal, Mphatso D. Kalemera, Charlotte B. Lewis, Machaela Palor, Lucas M. Walker, Tina Daviter, William Lees, David S. Moss, Myrto Kremyda-Vlachou, Zisis Kozlakidis et al. · 2022 · eLife
38. A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variants
    Naphak Modhiran, Simon Malte Lauer, Alberto Anastacio Amarilla, Peter Hewins, Sara Lopes van den Broek, Yu Shang Low, Nazia Thakur, Benjamin Liang, Guillermo Valenzuela, James Jung et al. · 2023 · iScience
39. Adaptive variations in SARS-CoV-2 spike proteins: effects on distinct virus-cell entry stages
    Enya Qing, Tom Gallagher · 2023 · mBio
40. Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes
    Xixi Zhang, Zimu Li, Yanjun Zhang, Yutong Liu, Jingjing Wang, Banghui Liu, Qiuluan Chen, Qian Wang, Lutang Fu, Peiyi Wang et al. · 2023 · Life Science Alliance
41. Mannose-Binding Lectins as Potent Antivirals against SARS-CoV-2
    Victória Riquena Grosche, Lucas Purificação Mendes de Souza, Giulia Magalhães Ferreira, Marco Fidel Guevara-Vega, Tamara Carvalho, Romério Rodrigues dos Santos Silva, Karla Lílian Rodrigues Batista, Rodrigo Paolo Flores Abuna, João S. Silva, Marília Freitas Calmon et al. · 2023 · Viruses
42. An effective drug against COVID-19: reality or dream?
    Atieh Yaghoubi, Saeid Amel Jamehdar, Aref Movaqar, Nasrin Milani, Saman Soleimanpour · 2020 · Expert Review of Respiratory Medicine
43. Nanoparticles for Coronavirus Control
    Maryam Kianpour, Mohsen Akbarian, Vladimir Nikolaevich Uversky · 2022 · Nanomaterials
44. Evaluation of Antibody-Dependent Fc-Mediated Viral Entry, as Compared With Neutralization, in SARS-CoV-2 Infection
    Lindsay Wieczorek, Michelle Zemil, Mélanie Merbah, Vincent Dussupt, Erin Kavusak, Sebastian Molnar, Jonah Heller, Bradley Beckman, Suzanne E. Wollen-Roberts, Kristina K. Peachman et al. · 2022 · Frontiers in Immunology
45. Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
    Mingtao Liu, Hui Gan, Zhiman Liang, Li Liu, Qiwen Liu, Yiyin Mai, Hui‐Huang Chen, Baoying Lei, Shangwei Yu, Huihui Chen et al. · 2023 · Frontiers in Microbiology
46. Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants
    Sylvia Rothenberger, Daniel L. Hurdiss, Marcel Walser, Francesca Malvezzi, Jennifer Mayor, Sarah Ryter, Héctor Moreno, Nicole Liechti, Andreas Bosshart, Chloé Iss et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
47. Analysis of the molecular mechanism of SARS-CoV-2 antibodies
    Dongfu Jin, Jing Wei, Jian Sun · 2021 · Biochemical and Biophysical Research Communications
48. Small Molecules Targeting SARS-CoV-2 Spike Glycoprotein Receptor-Binding Domain
    Yoel Rodrı́guez, Scarlet Martínez Cardoze, Onyinyechi W. Obineche, Claudia Melo, Ashanna Persaud, José A. Fernández Romero · 2022 · ACS Omega
49. Temperature Influences the Interaction between SARS-CoV-2 Spike from Omicron Subvariants and Human ACE2
    Shang Yu Gong, Shilei Ding, Mehdi Benlarbi, Yaozong Chen, Dani Vézina, Lorie Marchitto, Guillaume Beaudoin-Bussières, Guillaume Goyette, Catherine Bourassa, Yuxia Bo et al. · 2022 · Viruses
50. The Contribution of Biophysics and Structural Biology to Current Advances in COVID-19
    Francisco José Barrantes · 2021 · Annual Review of Biophysics
51. Neutralization of MERS coronavirus through a scalable nanoparticle vaccine
    Mona Omar Mohsen, Dominik A. Rothen, Ina Baļķe, B. E. E. Martina, Vilija Zeltina, Varghese Philipose Inchakalody, Zahra Gharailoo, Gheyath K. Nasrallah, Said Dermime, Kaspars Tārs et al. · 2021 · npj Vaccines
52. An Engineered Antibody with Broad Protective Efficacy in Murine Models of SARS and COVID-19
    C. Garrett Rappazzo, Longping V. Tse, Chengzi I. Kaku, Daniel Wrapp, Mrunal Sakharkar, Deli Huang, Laura M. Deveau, Thomas J. Yockachonis, Andrew S. Herbert, Michael B. Battles et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
53. A Rapid SARS-CoV-2 Nucleocapsid Protein Profiling Assay with High Sensitivity Comparable to Nucleic Acid Detection
    Jie Liu, Jinpeng Mao, Mengyu Hou, Zhian Hu, Gongwei Sun, Sichun Zhang · 2022 · Analytical Chemistry
54. Antibody‐mediated control mechanisms of viral infections
    Samantha Mackin, Alan Sariol, Michael Diamond · 2024 · Immunological Reviews
55. Structure and function analysis of a potent human neutralizing antibody CA521FALA against SARS-CoV-2
    Deyong Song, Wenbo Wang, Chuangchuang Dong, Zhenfei Ning, Xiu Liu, Chuan Liu, Guangying Du, Chunjie Sha, Kailin Wang, Jun Lu et al. · 2021 · Communications Biology
56. Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints
    Charles Eldrid, Joel D. Allen, Maddy L. Newby, Max Crispin · 2021 · Analytical Chemistry
57. Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies
    Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva · 2022 · Journal of Biomolecular Structure and Dynamics
58. Carbohydrates-based diagnosis, prophylaxis and treatment of infectious diseases: Special emphasis on COVID-19
    Popat Kumbhar, Anjali Pandya, Arehalli Sidramappa Manjappa, John Disouza, Vandana Bharat Patravale · 2021 · Carbohydrate Polymer Technologies and Applications
59. Characterization of the SARS-CoV-2 Spike in an Early Prefusion Conformation
    Tingting Li, Qingbing Zheng, Hai Jing Yu, Dinghui Wu, Wenhui Xue, Yuyun Zhang, Xiaofen Huang, Lizhi Zhou, Zhigang Zhang, Zhenghui Zha et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
60. The Importance of Glycosylation in COVID-19 Infection
    Tea Pribić, Gordan Lauc, Irena Trbojević‐Akmačić · 2021 · Advances in experimental medicine and biology
61. Dissecting the intricacies of human antibody responses to SARS-CoV-1 and SARS-CoV-2 infection
    Ruoke Wang, Yang Han, Rui Zhang, Jiayi Zhu, Xuanyu Nan, Yaping Liu, Ziqing Yang, Bini Zhou, Jinfang Yu, Zichun Lin et al. · 2023 · Immunity
62. Antibody-mediated spike activation promotes cell-cell transmission of SARS-CoV-2
    Shi Yu, Xu Zheng, Yanqiu Rachel Zhou, Yuhui Gao, Bingjie Zhou, Yapei Zhao, Tingting Li, Yunyi Li, Jiabin Mou, Xiaoxian Cui et al. · 2023 · PLoS Pathogens
63. Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants
    Qihong Yan, Xijie Gao, Banghui Liu, Ruitian Hou, Ping He, Yong Ma, Yudi Zhang, Yanjun Zhang, Zimu Li, Qiuluan Chen et al. · 2024 · Nature Communications
64. Pandemic COVID-19: Current status and challenges of antiviral therapies
    Winglam Chan, Betsy He, Xiong Wang, Ming He · 2020 · Genes & Diseases
65. Deciphering the protein motion of S1 subunit in SARS-CoV-2 spike glycoprotein through integrated computational methods
    Hao Tian, Peng Tao · 2020 · Journal of Biomolecular Structure and Dynamics
66. Monoclonal antibodies capable of binding SARS‐CoV‐2 spike protein receptor‐binding motif specifically prevent GM‐CSF induction
    X. Qiang, Shu Zhu, Jian-Hua Li, Weiqiang Chen, Huan Yang, Ping Wang, K. Tracey, Haichao Wang · 2021 · Journal of Leukocyte Biology
67. An Overview of Spike Surface Glycoprotein in Severe Acute Respiratory Syndrome–Coronavirus
    M. K. Kathiravan, Srimathi Radhakrishnan, Vigneshwaran Namasivayam, Palaniappan Senthilkumar · 2021 · Frontiers in Molecular Biosciences
68. Therapeutically effective covalent spike protein inhibitors in treatment of SARS-CoV-2
    Vikram Choudhary, Amisha Gupta, Rajesh Sharma, Hamendra Singh Parmar · 2021 · Journal of Proteins and Proteomics
69. The spike glycoprotein of highly pathogenic human coronaviruses: structural insights for understanding infection, evolution and inhibition
    Shuyuan Qiao, Shuyuan Zhang, Jiwan Ge, Xinquan Wang · 2022 · FEBS Open Bio
70. New-onset and relapsed Graves’ disease following COVID-19 vaccination: a comprehensive review of reported cases
    Kan Chen, Yiyang Gao, Jing Li · 2023 · European journal of medical research
71. A human antibody that broadly neutralizes betacoronaviruses protects against SARS-CoV-2 by blocking the fusion machinery
    Dora Pinto, Maximilian M. Sauer, Nadine Czudnochowski, Jun Siong Low, M. Alejandra Tortorici, Michael Patrick Housley, Julia Noack, Alexandra C. Walls, John E. Bowen, Barbara Guarino et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
72. Structural and functional characterizations of altered infectivity and immune evasion of SARS-CoV-2 Omicron variant
    Zhen Cui, Pan Liu, Nan Wang, Lei Wang, Kaiyue Fan, Qianhui Zhu, Kang Wang, Ruihong Chen, Rui Feng, Zijing Jia et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
73. Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study
    Taufik Muhammad Fakih, Mentari Luthfika Dewi · 2021 · Journal Of Tropical Pharmacy And Chemistry
74. Role of marine natural products in the development of antiviral agents against SARS-CoV-2: potential and prospects
    D. P. Nagahawatta, Nisansala Madushani Liyanage, Thilina Uduwaka Jayawardena, H.H.A.C.K. Jayawardhana, Seong-Hun Jeong, Hyung‐Jun Kwon, You‐Jin Jeon · 2024 · Marine Life Science & Technology
75. SARS-related coronavirus S-protein structures reveal synergistic RBM interactions underpinning high-affinity human ACE2 binding
    Jingjing Wang, Yong Ma, Zimu Li, Hang Yuan, Banghui Liu, Zexuan Li, Mengzhen Su, Gul Habib, Yutong Liu, Lutang Fu et al. · 2025 · Science Advances
76. Prepare for the Future: Dissecting the Spike to Seek Broadly Neutralizing Antibodies and Universal Vaccine for Pandemic Coronaviruses
    Luca Vangelista, Massimiliano Secchi · 2020 · Frontiers in Molecular Biosciences
77. Synthetic carbohydrate-binding agents neutralize SARS-CoV-2 by inhibiting binding of the spike protein to ACE2
    Oscar Francesconi, Lorena Donnici, Marco Fragai, Elisa Pesce, Mauro Bombaci, Alessandra Fasciani, Lara Manganaro, Matteo Conti, Renata Grifantini, Raffaele De Francesco et al. · 2022 · iScience
78. Maturation of SARS-CoV-2 Spike-specific memory B cells drives resilience to viral escape
    Roberta Marzi, Jessica Bassi, Chiara Silacci-Fregni, István Bartha, Francesco Muoio, Katja Culap, Nicole Sprugasci, Gloria Lombardo, Christian Saliba, Elisabetta Cameroni et al. · 2022 · iScience
79. COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte
    Xiaolong Gong, Amber Khan, Mohmmad Younus Wani, Aijaz Ahmad, Adriano Gianmaria Duse · 2022 · Journal of Infection and Public Health
80. Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials
    Pooya Farhangnia, Shiva Dehrouyeh, Amir Reza Safdarian, Soheila Vasheghani Farahani, Melika Gorgani, Nima Rezaei, Mahzad Akbarpour, Ali‐Akbar Delbandi · 2022 · International Immunopharmacology
81. Detection and Neutralization of SARS-CoV-2 Using Non-conventional Variable Lymphocyte Receptor Antibodies of the Evolutionarily Distant Sea Lamprey
    Leslie Y. T. Leung, Srijit Khan, Patrick Budylowski, Zhijie Li, Sofiya Goroshko, Yanling Liu, Shilan Dong, James R. Carlyle, James M. Rini, Mario Ostrowski et al. · 2021 · Frontiers in Immunology
82. Molecular determinants of cross-species transmission in emerging viral infections
    Arthur Wickenhagen, Sarah van Tol, Vincent Jacobus Munster · 2024 · Microbiology and Molecular Biology Reviews
83. Human coronavirus HKU1 spike structures reveal the basis for sialoglycan specificity and carbohydrate-promoted conformational changes
    Min Jin, Zaky Hassan, Zhijie Li, Ying Liu, Aleksandra Marakhovskaia, Alan H. M. Wong, Adam Forman, Mark Nitz, Michel Gilbert, Hai Yu et al. · 2025 · Nature Communications
84. HKU25 clade MERS-related coronaviruses use ACE2 as a functional receptor
    Chen Liu, Young‐Jun Park, Chengbao Ma, Risako Gen, Cameron Stewart, Yucheng Sun, Xiao Yi Yang, M C Lin, Qing Xiong, Jun-Yu Si et al. · 2025 · Nature Microbiology
85. Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · Journal of Biomolecular Structure and Dynamics
86. Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
    Gerwyn Morris, Eugene Athan, Ken R. Walder, Chiara C. Bortolasci, Adrienne E O'Neil, Wolfgang Marx, Michael Berk, Andre Ferrer Carvalho, Michael H. J. Maes, Basant K. Puri · 2020 · Life Sciences
87. Unravelling the molecular interactions between the SARS-CoV-2 RBD spike protein and various specific monoclonal antibodies
    Didac Martí, Marc Alsina, Carlos Alemán, Oscar Bertrán, Pau Turón, Juan Torras · 2021 · Biochimie
88. Influence of countries adopted social distancing policy for COVID-19 reduction under the view of the airborne transmission framework
    Charles Roberto Telles · 2020
89. Construction and bioanalytical applications of poly-adenine-mediated gold nanoparticle-based spherical nucleic acids
    Zhiwei Shang, Zixuan Deng, Xiaoqing Yi, Mengyu Yang, Xianliang Nong, Meihua Lin, Fan Xia · 2023 · Analytical Methods
90. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike
    Banghui Liu, Xuefeng Niu, Yijun Deng, Zhaoyong Zhang, Yanqun Wang, Xijie Gao, Huan Liang, Zimu Li, Qian Wang, Yuanyi Cheng et al. · 2024 · Cell Reports
91. Designing a Candidate Multi-Epitope Vaccine against Transmissible Gastroenteritis Virus Based on Immunoinformatic and Molecular Dynamics
    Yihan Bai, Mingxia Zhou, Naidong Wang, Yi Yang, Dongliang Wang · 2024 · International Journal of Molecular Sciences
92. Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base
    Sieglinde De Cae, Inge Van Molle, Loes van Schie, Sophie R. Shoemaker, Julie Deckers, Nincy Debeuf, Sahine Lameire, Wim Nerinckx, Kenny Roose, Daria Fijałkowska et al. · 2025 · Nature Communications
93. A broadly neutralizing antibody recognizes a unique epitope with a signature motif common across coronaviruses
    Lei Yan, Fulian Wang, Michelle L. Hill, Juliane Brun, Ze Liang, Xinyu Shi, L.Q. Zhang, Xin He, Yu Li, Qianping Huang et al. · 2025 · Nature Communications
94. Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · ACS Omega
95. Antigenicity of the Mu (B.1.621) and A.2.5 SARS-CoV-2 Spikes
    Debashree Chatterjee, Alexandra Tauzin, Annemarie Laumaea, Shang Yu Gong, Yuxia Bo, Aurélie Guilbault, Guillaume Goyette, Catherine Bourassa, Gabrielle Gendron‐Lepage, Halima Medjahed et al. · 2022 · Viruses
96. Predicting Epitope Candidates for SARS-CoV-2
    Akshay Agarwal, Kristen L. Beck, Sara Capponi, Mark Kunitomi, Gowri Nayar, Ed Seabolt, Gandhar K. Mahadeshwar, Simone Bianco, Vandana V. Mukherjee, James H. Kaufman · 2022 · Viruses
97. Coronaviruses' sugar shields as vaccine candidates.
    Denong Wang · 2020 · PubMed
98. Recent progress of surface plasmon resonance in the development of coronavirus disease-2019 drug candidates
    Qian Wang, Zhenming Liu · 2021 · European Journal of Medicinal Chemistry Reports
99. Severe Clinical Worsening in COVID-19 and Potential Mechanisms of Immune-Enhanced Disease
    John P. Hussman · 2021 · Frontiers in Medicine
100. Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
     Deepa Raghu, Pamela Hamill, Arpitha Banaji, Amy McLaren, Yu-Ting Hsu · 2021 · Journal of Pharmaceutical Analysis